Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guidance Model of Standardized Treatment of Antidepressants in Bipolar Disorder
NCT03148535Phase 4Unknown
- Sponsor
- Peking University
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in bipolar disorder (BD), sponsored by Peking University. Primary endpoint: Hamilton Rating Scale for Depression reduction ratio at 8 weeks. Status: unknown.
02
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03148535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148535.